For parents who cannot breastfeed, infant formula is not merely a product; it is a life-sustaining necessity. For millions, it is the sole source of nutrition during the most vulnerable months of human development. Yet, a growing body of evidence suggests that the industry responsible for this critical supply is operating under an "honor code" rather than a robust regulatory framework, leaving infants exposed to preventable pathogens and leaving grieving parents without justice.
Recent investigative reports from The Wall Street Journal, KFF Health News, and USA Today have exposed a disturbing trend: the federal government’s willingness to hold infant formula manufacturers criminally accountable for contamination has reached a vanishing point. As the Department of Justice (DOJ) shifts away from aggressive corporate enforcement, the burden of safety has been effectively offloaded onto the companies themselves—a move that prominent food safety attorneys warn is a recipe for disaster.
The Disappearing Prosecution: The Abbott Laboratories Case
The most glaring example of this shift involves the Justice Department’s handling of Abbott Laboratories. For years, federal investigators scrutinized Abbott over safety protocols at its facilities, where potentially deadly bacteria were discovered. These contamination events were linked to infant illnesses and deaths, and they significantly exacerbated the national formula shortage that gripped the United States.
According to those familiar with the investigation, federal prosecutors believed they had a strong case for criminal charges—a move consistent with how the DOJ has historically handled businesses that sell tainted food. However, despite the accumulation of a "pile of evidence," top-level decision-makers at the Justice Department opted to close the probe. Instead of pursuing criminal sanctions, the government chose a "lighter-touch" approach: clawing back financial gains the company earned through federally funded nutrition programs.
This pivot reflects a broader shift in federal policy. Under the current administration, the DOJ has explicitly moved away from "regulation by prosecution," following executive orders that prioritize civil penalties over criminal ones. Critics, including food safety lawyer Bill Marler, argue that this is a dangerous retreat. "The Consumer Protection Branch, which successfully put away the executives behind the Peanut Corporation of America salmonella outbreak, was disbanded as a cost-cutting measure," Marler notes. "When you remove the threat of jail time, you remove the primary deterrent for corporate negligence."
A System Built on an "Honor Code"
The regulatory failures extend beyond the courtroom and into the oversight processes of the Food and Drug Administration (FDA). An investigation co-published by KFF Health News and USA Today revealed that the current reporting system for infant formula "adverse events" is essentially toothless.
Under federal law, manufacturers are required to investigate complaints regarding their products. However, they are only mandated to notify the FDA within 15 days if they find a "reasonable possibility of a causal relationship" between their formula and an infant’s death. The operative word here is "if." Because the manufacturer conducts the investigation and determines the causality, the fox is effectively guarding the henhouse.
Data obtained through Freedom of Information Act requests reveals the chilling reality of this system: when asked for records of such notifications submitted by manufacturers since January 1, 2000, the FDA reported that it had zero records.
"The adverse event reporting system for infant formula is not a system at all," says Bill Marler, who currently represents families in two major infant botulism outbreaks tied to powdered formula—one involving ByHeart, which sickened at least 48 infants across 17 states, and another involving Nara Organics. "It is an honor code for an industry that litigation has shown may not deserve it."
The Financial Nexus: Politics, Profit, and Potential Conflict
The decision to drop the criminal investigation into Abbott Laboratories has raised questions regarding potential conflicts of interest. The sequence of events is, at minimum, a public relations nightmare for the government.
Records indicate that Abbott Laboratories contributed $500,000 to the current administration’s inaugural fund. Furthermore, public financial disclosures show that the President began accumulating Abbott stock during the same period the DOJ was weighing whether to proceed with criminal charges. Over the course of 2025, the President’s holdings in Abbott grew by approximately $500,000.
While no court has ruled that these financial links directly caused the DOJ to abandon the criminal probe, the optics are catastrophic. When high-level government policy aligns perfectly with the financial interests of a company under investigation, public trust in regulatory integrity evaporates. As one legal observer noted, the appearance of a "pay-to-play" dynamic—or, at the very least, a culture of extreme corporate leniency—is impossible to ignore when the lives of infants are the collateral damage.
Implications for Public Health and the Future of Regulation
The human cost of this regulatory vacuum is profound. Powdered infant formula is not sterile. While ordinary bacteria are usually harmless, pathogens like Cronobacter sakazakii or Clostridium botulinum can be lethal to newborns. Because infants have underdeveloped immune systems, even a small amount of contamination can lead to life-altering illness or death.
The industry argues that rigorous manufacturing standards are already in place, but the recurring nature of these outbreaks suggests that these standards are failing. The current reliance on civil settlements and clawbacks does little to incentivize the massive infrastructure upgrades required to ensure true product sterility.
The Path Forward: The Infant Formula Safety Modernization Act
In response to these systemic failures, there is a mounting push for legislative reform. The proposed Infant Formula Safety Modernization Act of 2026 aims to overhaul the existing regulatory framework, removing the manufacturer’s unilateral power to decide whether an adverse event is reported.
Key objectives of the proposed act include:
- Mandatory FDA Notification: Forcing companies to report all serious adverse events to the FDA immediately, regardless of the company’s own internal assessment of causality.
- Enhanced Inspection Authority: Granting the FDA greater power to perform unannounced, high-frequency inspections of formula production facilities.
- Criminal Liability Reform: Re-establishing the legal pathway for criminal charges against corporate executives who demonstrate "willful blindness" toward safety protocols.
"Legal slaps on the wrist will not stop food safety violations," says Marler. "We need a system that prioritizes the lives of the most vulnerable over the profitability of the most powerful."
Practical Advice for Parents
While legislative battles continue in Washington, parents are left in a difficult position. The medical consensus, though often difficult for families to implement due to cost and accessibility, is clear:
- Prioritize Liquid Formula: Liquid infant formula is typically commercially sterile, having undergone heat-treatment processes that effectively kill both living pathogens and bacterial spores.
- Understand the Risks of Powder: Powdered formula is not sterile. If powder must be used, follow the World Health Organization (WHO) guidelines: mix the powder with water that is at least 158°F (70°C) to kill potential pathogens, then cool it rapidly to a safe feeding temperature.
- Monitor Recalls: Stay vigilant regarding FDA recall notices and maintain a list of batch numbers for the products currently in your pantry.
The current state of infant formula safety is a failure of governance. When the government abandons its role as an impartial referee, the most vulnerable citizens are the ones who pay the price. Until Congress acts to pass meaningful, enforceable legislation, the responsibility remains squarely on the shoulders of parents to navigate a market where the safety of their child is, tragically, not guaranteed.
